Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
doi: 10.3389/fimmu.2025.1628142 Received 13 May 2025 Revised 01 December 2025 Accepted 15 December 2025 Published 14 January 2026 Volume 16 - 2025 Edited by Gaurisankar Sa, Bose Institute, India Reviewed by Dia Roy, Cleveland Clinic, United States Cadiele Oliana Reichert, University of So Paulo, Brazil Subhadip Pati, University of North Carolina at Chapel Hill, United States Updates Copyright 2026 Qian, Zhang, Bai, Li, Rao, Huang, Liu and Wei
Davis and Parish, 2013
TUG1 is overexpressed and oncogenic in many, though not all, cancers [79], but its potential actions through IGF-2 upregulation have not been explored in a cancer context
3c, Supplementary Fig
Introducing Beautywise Skin Brilliance with Dual-Action Technology, a scientifically developed solution that combines oil-based and water-based ingredients
US$ 20.87
US$ 28.61
US$ 24.55
US$ 27.65
